Another wave of private equity-backed bankruptcies is expected this year, according to the Private Equity Stakeholder Project.
Over 20% of healthcare bankruptcies last year were linked to private equity: report Read More »
Positive data for Lilly’s medicine tirzepatide in sleep apnea are the latest signal the benefits of GLP-1 agonists could extend beyond diabetes and weight loss.
Lilly obesity drug shows benefit in sleep disorder study, pointing to new use Read More »
Under the agreement, the FDA will use rare powers to require repairs, replacements or refunds for recalled respiratory machines.
‘An incredible undertaking’: 5 takeaways from Philips consent decree Read More »
CEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the recently approved Triclip valve a “billion-dollar opportunity.”
Abbott looks to ‘highly productive’ device pipeline for future growth Read More »
Soulaire marketed its external counterpulsation system to grow new arteries, repair organ dysfunction and treat COVID-19, among other uses, without evidence.
FDA warns Soulaire to stop selling device outside authorized uses Read More »
As its lead oral targeted protein degrader moves through Phase III in partnership with Pfizer, Arvinas signs a licensing deal handing over all rights and responsibilities to Novartis.
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space Read More »
After withdrawing ALS drug Relyvrio from the U.S. and Canadian markets and laying off 70% of its workforce, the Cambridge, Mass.–based biopharma got a much-needed win in Wolfram syndrome.
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio? Read More »
Amylyx looks to the future after Relyvrio withdrawal, ADCs continue to attract investment and the drug shortage persists in the U.S.
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages Read More »
¿Sabías que una negligencia médica puede tener consecuencias para el resto de tu vida? Denunciar puede prevenir futuros incidentes similares. ¿Qué es una Negligencia Médica? Una negligencia médica es una falla por …
¿Qué Hacer si Eres Víctima de una Negligencia Médica? Read More »
Orexo AB, announces that the United States Patent and Trademark Office has granted another US patent specifically related to OX640, Orexo’s nasal epinephrine powder product based on the AmorphOX® drug delivery platform.
Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US Read More »
